Breaking News

LLS Selects INC Research for AML Master Trial

Will provide a full range of CRO services

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

The Leukemia & Lymphoma Society (LLS) has selected INC Research to manage its recently-launched precision medicine Master Trial to treat acute myeloid leukemia (AML). The Beat AML Master Trial is the first time a non-profit is working with multiple pharma and biopharma sponsors and other key collaborators to operationalize a study. The trial will provide principal investigators and their patients consolidated access to test novel therapies matched to specific molecular aberrations in AML.  ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters